StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Precision BioSciences

Precision BioSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Precision BioSciences figures

See a number that looks wrong?